Glioblastoma represents the most lethal form of brain cancer, characterized by a 5-y survival rate of approximately 4%. Fibroblast activation protein (FAP), expressed within both the tumor ...

DULLES, Va., Dec. 29, 2025 /PRNewswire/ -- SOFIE Biosciences, an established U.S. manufacturer and developer of radiopharmaceuticals, today announced that the first patient has been dosed in one of ...

DULLES, Va., Nov. 29, 2022 /PRNewswire/ -- SOFIE Biosciences (SOFIE), an established US manufacturer and developer of radiopharmaceuticals, has received Investigational New Drug (IND) clearance to ...

Increased Research Activity: A significant surge in FAP-related publications was observed starting in 2019, with China, the USA, and Germany leading in productivity and international collaboration.

Vadodara: Bhailal Amin Cancer Centre has become the first facility in Gujarat to introduce Terbium-161 FAPI PTRT (Peptide Targeted Radionuclide Therapy), an advanced nuclear medicine treatment aimed ...

SOFIE Biosciences, an established US manufacturer and developer of radiopharmaceuticals, announced that the first patient has been dosed in the second of its two phase 3 clinical trials evaluating 18F ...